SUMMARY OF PRODUCT CHARACTERISTICS NAME OF THE MEDICINAL PRODUCT Digoxin KERN PHARMA 0.25 mg tablets QUALITATIVE AND QUANTITATIVE COMPOSITION Digoxin KERN PHARMA 0.25 mg tablets

SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Dipyridamole 100mg Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION

4 CLINICAL PARTICULARS 4.1 Therapeutic indications As an adjunct to oral anti-coagulation for prophylaxis of thromboembolism associated with prosthetic heart valves. In combination with aspirin for: a. Prophylaxis of deep venous thrombosis as an alternative to subcutaneous heparin, other than in hip surgery. b. Prophylaxis of recurrent venous thrombosis resistant to oral anticoagulation. c. Pro...

SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Clarithromycin 500 mg Powder for Solution for Infusion 2 QUALITATIVE AND QUANTITATIVE COMPOSITION

4.1 Therapeutic indications Clarithromycin 500 mg Powder for solution for Infusion is indicated whenever parenteral therapy is required for treatment of infections caused by susceptible organisms in the following conditions; Lower respiratory tract infections for example, acute and chronic bronchitis, and pneumonia. Upper respiratory tract infections for example, sinusitis and pharyngitis. Skin...

KEMADRIN Tablets Procyclidine Hydrochloride 5 mg Tablets Qualitative and Quantitative Composition

SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Vitamin A-POS 250 I.U./g, eye ointment, 2. QUALITATIVE AND QUANTITATIVE COMPOSITION

4.1 Therapeutic Indications Supportive therapy for atrophic changes of the cornea and conjunctiva caused by vitamin A deficiency (e.g Keratomalacia, Xerophthalmia) and for trophic disturbances of cornea and conjunctiva caused by mucin deficiency by a well preserved protecting serous film. 4.2 Posology and Method of Administration Instil one strip of eye ointment 3 times daily (especially at nig...

Developing a Model for Agile Supply: an Empirical Study from Iranian Pharmaceutical Supply Chain

Agility is the fundamental characteristic of a supply chain needed for survival in turbulent markets, where environmental forces create additional uncertainty resulting in higher risk in the supply chain management. In addition, agility helps providing the right product, at the right time to the consumer. The main goal of this research is therefore to promote supplier selection in pharmaceutica...